Targeted News Service

Falk Pharma Acquires Kynos Therapeutics
December 03, 2024

BOSTON, Massachusetts, Dec. 3 -- Goodwin, a law firm, issued the following news release:

The London Life Sciences team advised Kynos Therapeutics Limited ("Kynos Therapeutics") and its selling shareholders on its sale to Dr. Falk Pharma GmbH ("Dr Falk").

Kynos Therapeutics is a clinical stage biopharmaceutical company focusing on the development of novel treatments for patients suffering from acute and chronic inflammatory diseases. The company was f . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form